Current Report Filing (8-k)
November 16 2017 - 9:45AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO
SECTION
13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
November 14, 2017
EARTH
SCIENCE TECH, INC.
|
(Exact
Name of Registrant as Specified in its Charter)
|
Nevada
|
(State
or Other Jurisdiction of Incorporation)
|
000-55000
|
|
45-4267181
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
8000
NW 31
st
Street, Suite 19
Doral,
FL
|
|
33122
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(Registrant’s
telephone number, including area code):
(305) 615-2118
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.)
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
1.01. Entry into Material Definitive Agreement.
Services
Agreement for Lab Verifications of New Products
On
November 14, 2017, the Registrant, through Canna Inno Laboratories, Inc., entered into a services agreement with TransBIOTech,
a member of Quebec Innove. More information about TransBIOTech and Quebec Innove can be found here:
http://www.tbt.qc.ca/en/
,
https://www.quebecinnove.com
.
Pursuant
to the agreement, TransBIOTech will test the biological activity of the Registrant’s new nutraceutical products in vitro,
and then in vivo. Management believes TransBIOTech has the requisite experience in analytic chemistry to confirm that the Registrant
is offering a stable product of very high quality.
Management
believes TransBiotech can analyze and test ETST’s nutraceuticals and functional foods by employing chemistry analysis, based
on the measurement of antioxidant capacity (ORAC), analysis of polyphenols, flavonoids, and fatty acid profiles (including omega-3,
omega-6, EPA, DHA), amino acids, monosaccharides, and others.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
EARTH
SCIENCE TECH, INC.
|
|
|
Dated:
November 15, 2017
|
/s/
Nickolas S. Tabraue
|
|
Nickolas
S. Tabraue
|
|
President
and COO
|
Earth Science Tech (PK) (USOTC:ETST)
Historical Stock Chart
From Apr 2024 to May 2024
Earth Science Tech (PK) (USOTC:ETST)
Historical Stock Chart
From May 2023 to May 2024